^
Association details:
Biomarker:No biomarker
Cancer:Ovarian Cancer
Drug:topotecan (Topoisomerase I inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Excerpt:
Topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Ovarian cancer: Preferred regimens….Topotecan